Teva
Cephalon accepts Teva’s $6.8 billion white knight bid
May 3, 2011Research and Development, Sales and Marketing Cephalon, Teva, Valeant, generics
Generics giant Teva has acquired Cephalon for $6.8 billion and says the deal will make it a leading specialty pharmaceutical …
Teva’s Irvine facility gets FDA green light
May 3, 2011Manufacturing and Production FDA, Teva, manufacturing compliance
Teva Pharmaceutical Industries has said that an injectables facility in the USA, shut down last April after quality control problems, …
Pharma manufacturing news in brief
April 26, 2011Manufacturing and Production Archer Daniels Midland, Dow Chemical, IPEC Americas, Pharmatek Laboratories, Taro, Taro Pharmaceutical Industries, Teva, Teva Pharmaceutical Industries, manufacturing, manufacturing news in brief, pharma manufacturing news
Includes a formulation problem for Teva, facility updates from Taro and ADM, and a new excipient screening initiative at the …
Teva surges ahead
February 9, 2011Sales and Marketing 2010 pharma results, Copaxone, Teva, Teva Pharmaceutical
Generics giant Teva enjoyed a strong year of growth in 2010, lifted by the acquisition of Ratiopharm, patent expiries of …
Teva plant in Israel cited by FDA, expands in Americas
February 8, 2011Manufacturing and Production Corporacion Infarmasa, FDA, Peru, Teva, Teva Pharmaceutical, generics, generics manufacturing, manufacturing compliance
A manufacturing facility in Jerusalem operated by Teva Pharmaceutical failed to pass muster in an FDA inspection, prompting a warning …
Novartis challenges Roche with MabThera biosimilar
January 11, 2011Research and Development Lonza MabThera, Novartis, Roche, Teva, biosimilar, rituximab
Novartis’ generics unit Sandoz has begun mid-stage trials of a biosimilar version of Roche’s blockbuster drug MabThera. The phase II …
Digital Pharma: Pharma iPhone app update
October 15, 2010Medical Communications Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone
The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …
Two $1 billion dollar acquisition deals go through
August 11, 2010Sales and Marketing Alcon, M&A, MA, Novartis, Ratiopharm, Teva
Two major acquisition deals mounted by Teva and Novartis are in their final stages as they move to complete potentially …
Teva will invest $56m in Canadian plant
June 7, 2010Manufacturing and Production Canada, Teva, production
Israeli generic drugmaker Teva Pharmaceutical Industries is planning to spend $54 million to expand a Canadian production plant for solid …
Teva staff in Ireland vote for industrial action
June 3, 2010Manufacturing and Production Ireland, Teva
Workers at a plant operated by Teva in Ireland have voted to take industrial action in a dispute over redundancy …
Teva reports strong Q1 results
May 10, 2010Sales and Marketing 2010 financials, Teva
Generics firm Teva Pharmaceuticals has reported strong first quarter results, driven by its patented multiple sclerosis therapy Copaxone. Sales of …
FDA warns Teva over California plant
April 30, 2010Manufacturing and Production Teva, manufacturing compliance
Teva has become the latest drugmaker to be rebuked by the FDA for not responding effectively enough to compliance problems …
Merck to be hit by Cozaar generics
April 9, 2010Merck, Teva, generics
Generic versions of Merck’s hypertension treatments Cozaar and Hyzaar are to be launched in the US for the first time. …
Teva to buy Ratiopharm for €3.6 billion
March 18, 2010Sales and Marketing Ratiopharm, Teva
Teva has secured the acquisition of German generics business Ratiopharm with a last minute bid of 3.62 billion euros. Teva …
Pfizer muscles in on Ratiopharm sale
March 11, 2010Sales and Marketing Pfizer, Ratiopharm, Teva, generics
Pfizer has reportedly bid $4 billion for German generics firm Ratiopharm in a bid to rapidly expands its portfolio in …
